Childhood Brugada Syndrome in Two Korean Families by Lee, Yun Sik et al.
 
 
  143
CASE REPORT 
DOI 10.4070 / kcj.2010.40.3.143 
Print ISSN 1738-5520 / On-line ISSN 1738-5555
Copyright ⓒ 2010 The Korean Society of Cardiology
Open Access   
Childhood Brugada Syndrome in Two Korean Families 
 
Yun Sik Lee, MD
1, Jae Suk Baek, MD
1, So Yeon Kim, MD
2, Sang Won Seo, MT
3, Bo Sang Kwon, MD
1,  
Gi Beom Kim, MD
1, Eun Jung Bae, MD
1, Sung Sup Park, MD
2 and Chung Il Noh, MD
1 
1Departments of Pediatrics and 
2Laboratory Medicine, Seoul National University College of Medicine, Seoul,   
3Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea 
 
ABSTRACT 
Since the first descriptions of Brugada as a new clinical entity defined by sudden cardiac death in patients with 
typical electrocardiogram (ECG) patterns, Brugada syndrome (BS) has been increasingly diagnosed. This syndrome 
is known as a disease that is inherited via an autosomal dominant trait, and the SCN5A mutation has been found 
in 20-25% of BS patients. Because BS primarily manifests in adulthood, little information is available on BS 
during childhood. Although there have been several reports on adult BS in Korea, pediatric BS has not been 
reported. Herein, we report on childhood BS in two families. One infantile BS patient and his family had a 
novel SCN5A mutation (c.4035G>T, p.W1345C, heterozygote) in domain III of the sodium channel. (Korean 
Circ J 2010;40:143-147) 
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Introduction 
 
In 1992, Brugada syndrome (BS) was first described 
as a new clinical entity characterized by a typical elec-
trocardiogram (ECG) pattern {right bundle branch block 
(RBBB) and persistent ST-segment elevation in right 
precordial leads} and sudden cardiac death.
1)2) After the 
first formal description in the medical literature, this 
clinical entity has been increasingly diagnosed.
2-4) In 
patients with BS, sudden onset of ventricular tachycar-
dia may develop; when this arrhythmia persists, it can 
degenerate into ventricular fibrillation, resulting in sud-
den cardiac death. BS is known as a disease that is in-
herited via an autosomal dominant mode of transmis-
sion with varying penetration.
2)5) Although this syndrome 
is commonly known to manifest in adulthood, usually 
in the fifth decade, some pediatric cases have been re-
ported, including one of a 2 day-old infant.
6) 
To the best of our knowledge, there have been no re-
ports on BS in Korean children. We report on child-
hood BS in two families.   
 
Cases 
 
Case 1 
A one-month-old male infant presented to the out-
patient-department (OPD) for systolic murmur. Echo-
cardiogram revealed perimembranous ventricular sep-
tal defect (VSD) with septal aneurysm. ECG was ob-
tained and showed right axis deviation with possible 
RBBB (Fig. 1A). The patient visited OPD regularly, and 
no remarkable symptoms were found. Because the VSD 
was of moderate size without significant hemodynamic 
compromise, the patient underwent routine observa-
tion for VSD. When he was 4 months old, ECG reveal-
ed significant QRS widening in right precordial leads, 
with saddle back ST elevation in the V3 lead (Fig. 1B). 
The pattern of ECG changed progressively until 6 mon-
ths of age, when definitive ST elevation with T wave 
inversion of Brugada type 1 pattern was observed (Fig. 
1C). At 24-hour Holter monitoring, rare, premature 
ventricular contractions (<1%) were recorded without 
run. The patient had no family history of syncope or 
sudden death. Initial ECGs of family members, in-
cluding his parents and sister, were negative. However, 
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ECG taken during the 2 mg/kg flecainide challenge 
test revealed a type 1 Brugada pattern in both father 
and mother (Fig. 2). A familial genetic sequencing study 
for SCN5A was performed. Deoxyribonucleic acid (DNA) 
sequencing analysis of the cardiac sodium channel (SC-
N5A) revealed a G to T base substitution at nucleotide 
position 4035 on exon 23 that led to replacement of 
tryptophan by cysteine at codon 1345 (c.4035G>T, 
p.W1345C, heterozygote) in domain III of the sodium 
channel (Fig. 3B). Study of the patient’s father reveal-
ed no mutation, but the same novel mutation as that 
of the patient was found in a study of the mother (Fig. 
3C). No other SCN5A mutations were found. This mu-
tation was not detected in 101 unrelated control sub-
jects. Genetic studies on maternal family members are 
recommended. This child with manifest Brugada type 
ECG with SCN5A mutation is asymptomatic at this 
point; thus, he is being closely monitored without tr-
eatment. 
 
Case 2 
A 12-year-old boy and his 10-year-old sister were 
referred to the pediatric cardiology OPD for familial 
history of sudden death. Their father had died of sud-
den cardiac arrest after some alcohol intake at the age 
of 44 years. He had no history of previous syncopal at-
tack and no other significant medical history. Cardiac 
arrest was suspected to be due to ventricular tachycar-
dia associated with BS by the attending physician. The 
patients’ paternal great grandfather died during sleep 
in his fifth decade. The brother and sister had no me-
dical history or symptoms, such as chest discomfort, syn-
cope, or palpitation. Their ECGs and Holter monitor-
ings revealed no significant abnormality. Echocardio-
gram showed normal cardiac structures. On arrhythmia 
drug test with flecainide, the boy showed typical coved 
type ST elevation in the precordial leads V1 to V3 (after 
13 doses of flecainide 8 mg, 2.7 mg/kg) (Fig. 4A), and 
the girl also revealed typical coved type ST elevation in 
A  B  C  D 
Fig. 2. Parental ECG changes in case 1 on flecainide challenge tests. A: baseline ECG record of the father in case 1. No definite ab-
normality, but suspicious ST elevation is observed. B: ECG of the father in case 1 obtained after flecainide challenge. Equivocal coved
ST-segment elevation followed by T wave inversion (type 1 Brugada pattern) is observed (arrow). C: baseline ECG record of the mother
in case 1. Normal sinus rhythm without ST-segment elevation is observed. D: ECG of the mother in case 1 obtained after flecainide
challenge. Considerable QRS widening with coved ST-segment elevation followed by T wave inversion (type 1 Brugada pattern) is ob-
served in V1 and V2 leads (arrows). ECG: electrocardiogram. 
A  B  C 
Fig. 1. Serial change of ECG with age in case 1. A: ECG obtain-
ed at 1 month of age. Normal sinus rhythm with right axis deviation
and possible RBBB pattern are observed. B: ECG at 4 months
of age. Significant QRS widening in right precordial leads with
saddle back ST elevation in the V3 lead is observed (arrow). C:
ECG at 6 months. Definitive ST elevation with T wave inversion of
Brugada type 1 pattern is observed (arrows). ECG: electrocardio-
gram, RBBB: right bundle branch block.  
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the precordial leads V1 to V3 (after 10 doses of flecainide 
10 mg, 1.9 mg/kg) (Fig. 4B). Programmed ventricular sti-
mulation test showed no inducible ventricular tachy-
cardia in either patient. Genetic study for SCN5A was 
performed for the female patient, but no causative mu-
tation was detected. Both patients are in good condi-
tion, without medication or symptoms after discharge. 
Implantable cardioverter-defibrillators (ICDs) are under 
consideration if symptoms or signs develop. 
 
Discussion 
 
BS is a disease of adulthood, typically resulting in 
sudden death during the forties
6)7); however, some cases 
have reported on childhood BS in patients as young as 
a few days old. Since it was first formally reported in 
1992, numerous studies and reports on the clinical 
characteristics or the genetic and molecular aspects of 
the disease have appeared.
2)8)9) Now BS is regarded as 
responsible for 4% to 20% of all sudden death, and 
up to 20% of sudden death without structural heart 
disease.
6)9) Characteristic ECG patterns were identified 
soon after the first report: 1) type-1 ECG pattern was 
described in the initial report, where a coved ST-seg-
ment elevation greater than or equal to 2 mm is follow-
ed by a negative T wave in more than 1 right precor-
dial lead (V1-V3); 2) type-2 ECG pattern is characte-
rized by an ST-segment elevation, followed by a posi-
tive or biphasic T wave that together compose a saddle-
back morphology; 3) type-3 ECG pattern is characte-
rized by a right precordial ST-segment elevation less 
than or equal to 1 mm with either a coved-type or a sad-
dle-back morphology.
2)10) Although all of these 3 ECG 
patterns can be identified in patients with BS, only the 
type-1 ECG pattern now defines diagnosis of the syn-
drome.
6)10) The proband of the first family in this re-
port showed dramatic progression of the Brugada type 
ECG pattern from simple RBBB to type 1 pattern dur-
ing the first half of the boy’s infancy (Fig. 1). Because 
the patient in case 1 had VSD and septal aneurysm, 
the initial RBBB change on ECG could possibly be 
associated with the malformation itself. However, as 
demonstrated in Fig. 1, ECG progression to typical coved 
type ST segment elevation in V1-V3, which is the ch-
aracteristic feature of BS, could have led to the diag-
nosis of BS. BS can be diagnosed when a type-1 ECG 
pattern is observed in more than 1 right precordial lead 
(V1-V3), with or without a sodium channel blocker 
agent, and in concurrence with one of the following: 
documented ventricular fibrillation, polymorphic ven-
tricular tachycardia, inducibility of ventricular arrhyth-
mias with programmed electrical stimulation, family 
history of sudden death before the age of 45 years, pre-
sence of coved-type ECG in family members, syncope, 
and nocturnal agonal aspiration.
2)6)10)  
A 
B 
C 
Fig. 3. DNA sequencing analysis for the cardiac sodium chan-
nel (SCN5A). A: study of normal control individual. B: genetic
study of case 1 revealed a novel mutation comprised of a G to T
base substitution at nucleotide position 4035 that led to repla-
cement of tryptophan by cysteine at codon 1345. C: DNA sequ-
encing analysis of the mother in case 1. The same SCN1A gene
mutation as in case 1 was found in the genetic study of the mo-
ther. DNA: deoxyribonucleic acid. 
A  B 
Fig. 4. ECG changes of patients in case 2 after the flecainide
challenge test. A: ECG of a 12 year old boy after the flecainide
challenge test. Typical coved ST-segment elevation followed by
T wave inversion is observed on V1 and V2 leads. B: ECG of a
10 year old girl after the flecainide challenge test. Note the ty-
pical Brugada pattern ST-segment elevation on V1 and V2 leads.
ECG: electrocardiogram.  
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Although some sporadic cases of BS have been re-
ported, it is now understood as an inherited disease, in 
which a familial occurrence was noted in approxima-
tely half of patients.
2)4) The first description of a re-
lated mutation appeared in 1998 and identified the 
mutation in SCN5A, the gene encoding the alpha sub-
unit of the cardiac sodium channel.
11)12) To date, 100 
or more other mutations found in SCN5A have been 
associated with this syndrome, and a second locus was 
found on chromosome 3p22-25 without identification 
of the causative gene.
2)13) However, only 20-25% of BS 
shows mutations in SCN5A. Our first proband with 
infantile manifestation had a novel mutation (c.4035G 
>T, p.W1345C, heterozygote) equal to that of the mo-
ther. However, the mother was asymptomatic, and Bru-
gada type ECG was uncovered only by flecainide in-
jection. This may be due to low penetrance. However, 
there may be another explanation for the spontaneous 
change of ECG in case 1 during infancy. This case may 
have another undefined predisposition because the fa-
ther of the child showed equivocal type 1 Brugada pat-
tern ST elevation by flecainide, despite having no do-
cumented SCN5A mutation. As the SCN5A mutation 
was not found in up to 70% of BS cases, we can specu-
late that the father of the patient may have an unde-
fined or unknown mutation causing BS or a genetic 
polymorphism with predisposal to BS type ST change 
under certain provocations. On the other hand, we still 
cannot exclude the possibility of a false positive result 
for the father on the flecainide provocation test, as the 
specificity of the provocation test has been reported to 
be 80% in adults, leaving a 20% false positive rate. How-
ever, it should be noted that racial differences could be 
reflected in the specificity of the provocation test. As a 
study targeting both adults and children in the Korean 
population has not yet been reported, further study tar-
geting the Korean population may help to explain the 
discrepancy between results from genetic analysis and 
the provocation test. Current opinions do not support 
the role of genetic analysis in estimation of risk for BS
5); 
however, it may be helpful in detection of asymptoma-
tic carriers of the mutation, who may then be provided 
with clinical monitoring. SCN5A mutations resulted pri-
marily in the production of either a non-conducting so-
dium channel or accelerated recovery of the sodium 
channel. The functional effect of the mutations in tr-
ansmembrane domain III, W1345C, has not yet been 
documented.  
Several factors have been known to trigger typical 
Brugada-pattern ECG and polymorphic ventricular ta-
chycardia in susceptible individuals. These factors in-
clude autonomic imbalance, electrolyte imbalance, fever, 
myocardial ischemia, and drugs, including antiarrhyth-
mic agents, psychotropic drugs, alpha adrenergic ago-
nists, potassium channel opening drugs, and first gene-
ration antihistamines.
5)6) 
The only proven treatment option for BS is an ICD.
14) 
Within the current guidelines, implantation of ICD is 
indicated for patients with BS and aborted cardiac ar-
rest who receive optimal long-term treatment and whose 
life expectancy in good general condition exceeds one 
year.
5)15) 
In the first report of BS, 3 of the 8 patients were child-
ren
1); however, little information on this syndrome dur-
ing childhood has been available. It can manifest during 
childhood, and symptoms may appear during febrile 
episodes.
16) Symptomatic childhood patients, particu-
larly those presenting with a spontaneous type-1 ECG, 
may be at a high risk for cardiac events during a re-
latively short period of follow-up.
2) The first descrip-
tion of BS in children appeared in the literature in 
2000.
7)17) Since that time, many cases of pediatric BS have 
been reported. In three Japanese studies describing the 
prevalence and clinical course of childhood BS,
7)18-20) 
typical ECG patterns of BS were found less frequently 
than in adult studies; however, this prevalence increas-
ed with age. The nature of BS is known to be dynamic, 
and this variability is more prominent in children.
20)  
To the best of our knowledge, there have been no re-
ports on BS in Korean children. We reported on child-
hood BS in two families; one family had a novel SC-
N5A mutation. Physicians should be aware of this po-
tentially lethal disease, which may manifest even in in-
fancy, resulting in sudden infant death syndrome.
4)17) 
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